Calidi Biotherapeutics (CLDI) Other Non-Current Assets (2021 - 2026)
Calidi Biotherapeutics' Other Non-Current Assets came in at $200,000 for Q2 2026, up 100.0% from $100,000 a year earlier.
Powered by 
Analysis
Calidi Biotherapeutics (CLDI) Other Non-Current Assets (2021 - 2026) Analysis & Trends
At the end of FY2025, Calidi Biotherapeutics' Other Non-Current Assets was $138,000, down 9.2% from FY2024.
- Other Non-Current Assets has declined in each of the last three years, with a four-year compound annual growth rate of -16.3% (FY2021 to FY2025).
- Going back by year, Other Non-Current Assets was $152,000 in FY2024 (-59.2%), $373,000 in FY2023 (-48.6%), $725,000 in FY2022 (+158.1%) and $280,944 in FY2021.
- The five-year range for quarterly Other Non-Current Assets is $77,033 (Q2 2022) to $1.29 million (Q3 2023).
- Year-over-year, Other Non-Current Assets increased in 1 of the last seven quarters, with an average decline of 25.1%.
- The fastest year-over-year change in Other Non-Current Assets over five years came in Q4 2022 (growth of 158.1%), and the weakest in Q3 2024 (a decline of 83.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,149.64 Bn | 1,118.23 Bn | 19.71 Bn | 7.48 Bn |
| 2 | Johnson & Johnson | 626.55 Bn | 545.08 Bn | 17.26 Bn | 14.27 Bn |
| 3 | AbbVie | 498.79 Bn | 471.91 Bn | 12.70 Bn | 10.73 Bn |
| 4 | Merck | 371.66 Bn | 326.04 Bn | 12.21 Bn | 19.60 Bn |
| 5 | Novartis Ag | 299.96 Bn | 263.95 Bn | 11.24 Bn | 5.93 Bn |
| 6 | Astrazeneca | 263.22 Bn | 236.91 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.03 Bn | 192.43 Bn | 7.24 Bn | 12.98 Bn |
| 8 | Gilead Sciences | 191.20 Bn | 165.40 Bn | 6.22 Bn | 4.75 Bn |
| 9 | Pfizer | 170.83 Bn | 117.47 Bn | 10.94 Bn | 9.94 Bn |
| 10 | Calidi Biotherapeutics | 1.09 Mn | -24.29 Mn | - | 209,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 209,000.00 |
| Dec 31, 2025 | 138,000.00 |
| Sep 30, 2025 | 340,000.00 |
| Jun 30, 2025 | 140,000.00 |
| Mar 31, 2025 | 344,000.00 |
| Dec 31, 2024 | 152,000.00 |
| Sep 30, 2024 | 417,000.00 |
| Jun 30, 2024 | 427,000.00 |
| Mar 31, 2024 | 706,000.00 |
| Dec 31, 2023 | 373,000.00 |
| Sep 30, 2023 | 1.64 Mn |
| Dec 31, 2022 | 725,000.00 |
| Jun 30, 2022 | 77,033.00 |
| Mar 31, 2022 | 178,988.00 |
| Dec 31, 2021 | 280,944.00 |
API Access
Calidi Biotherapeutics Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=CLDI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "CLDI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=CLDI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();